# Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer

> **NCT01290354** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 10 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Lapatinib
- **DRUG:** [11C] lapatinib

## Key facts

- **NCT ID:** NCT01290354
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-12
- **Primary completion:** 2013-03-18
- **Final completion:** 2013-03-18
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290354, "Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01290354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*